Endpoints News
How Seaport is hedging against failure in Phase 2b depression study
Endpoints News
A week of bolt-on deals; Wave crashes on obesity data; Sanofi partners with TCE startup; and more
Welcome back to Endpoints Weekly! Our team tracked a handful of deals announced this week as the first quarter comes to a close. Check below for a summary of those moves, including Merck’s $6.7 billion …
Otsuka is buying neuropsychiatric drugmaker Transcend Therapeutics in a deal worth roughly $1.2 billion, further bolstering a class of drugs that are supposed to provide the therapeutic benefits of psychedelics without the trip.
As part …
The European Medicines Agency’s human medicines committee has recommended the approval of four new drugs and a new form of Sanofi’s multiple myeloma drug.
CHMP gives its opinions on drug approvals and label expansions to …
2026 DIA/FDA Oligonucleotide-Based Therapeutics Conference – 09/23/2026
Public Meeting on the Recommendations for Reauthorization of the Prescription Drug User Fee Act (PDUFA) – 09/16/2026
List of Determinations Including Written Request
RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations – 09/29/2026
STAT+: Definium’s LSD therapy eased anxiety in second large trial
With pharmaceutical tariffs looming, guidance on compliance is still lacking
-
Fierce Biotech6 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
-
Endpoints News6 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
-
Uncategorized6 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
-
Nature Biotechnology6 months ago
Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy
-
Uncategorized4 months agoOptical Pooled CRISPR Screen Reveals Regulators of NF-κB Dynamics in Human Cells
-
Uncategorized4 months ago
Relay’s PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
-
STAT News – Biotech6 months agoSTAT+: In private meetings, White House works to win pharma companies’ support for drug pricing bill
-
BioPharma Dive – AI / Data6 months agoAstraZeneca lung drug gets ‘surprise’ win in COPD trials
Scan to Read